Home Journals Subjects About My LA Reviewers Authors News Submit
.
(close)

(Ctrl-click to select multiple journals)


How should we address you?

Your email address


Enter the three character code
Visual CAPTCHA
Privacy Statement

Gastroenterology

Get Updates

Gastroenterology research articles, Gastroenterology research article, Gastroenterology journals, Gastroenterology journal, Gastroenterology articles, Research on Breast cancer, Gastroenterology



Sign up for free journal updates
How should we address you?
Your email address
Enter the three character code
Visual CAPTCHA

peer reviewed open access journals 80




Latest news
  • Biomarker Insights Editor in Chief co-author of Nature cover story
  • - 06/May/2010
  • Author interview with Dr Thomas Ostermann
  • - 24/Mar/2010
  • Author interview with Dr Yoshihito Yokoyama
  • - 11/Mar/2010
  • Author interview with Dr Ross Grant
  • - 11/Mar/2010
  • Follow our open access journals on Twitter
  • - 11/Mar/2010
  • Published in February
  • - 11/Mar/2010
  • New article notifications in your in-box
  • - 22/Feb/2010
  • Indian Journal of Clinical Medicine introductory editorial available
  • - 11/Feb/2010
  • Published in January
  • - 11/Mar/2010
  • Seven more journals added to CAS
  • - 26/Jan/2010
  • Directory of Open Access Journals interview
  • - 28/Jan/2010
  • Author interview with Dr Hiro Koshiyama
  • - 28/Jan/2010
  • Author interview with Dr Nicolas Carels
  • - 22/Jan/2010
  • Interview with Clinical Medicine Insights: Cardiology editorial board meber Dr Arnon Blum
  • - 12/Jan/2010
  • Five more journals accepted by DOAJ
  • - 05/Jan/2010
  • Open access articles published in December
  • - 04/Jan/2010
  • Open access articles published in November
  • - 09/Dec/2009
  • 2010 special issues
  • - 07/Dec/2009
  • Proposals invited for Translational Oncogenomics special issue
  • - 07/Dec/2009
  • Proposals invited for Signal Transduction Insights special issue
  • - 07/Dec/2009
  • Proposals invited for Rehabilitation Process and Outcome special issue
  • - 07/Dec/2009
  • Proposals invited for Primary Prevention Insights special issue
  • - 07/Dec/2009
  • Proposals invited for Perspectives in Medicinal Chemistry special issue
  • - 07/Dec/2009
  • Proposals invited for Palliative Care: Research and Treatment special issue
  • - 07/Dec/2009

Latest pictures




Latest articles

Most read articles


(previous 30 days)Site updates
51
Articles published:
1
Comments:
3
Blog entries:
Get Updates
Get Updates
Get Updates
Abstract
Full-text PDF

Microscopic Colitis and Medication Use     (18/May/2010)


Background: The incidence of microscopic colitis (MC) is increasing, but its etiology remains unknown. Case reports and limited controlled data suggest that commonly prescribed drugs may be triggers. The aim of this study was to evaluate the prevalence of selected medication use [Proton pump inhibitors (PPIs), HMG-CoA reductase inhibitors...


Abstract
Pay-per-view

The Efficacy of Mosapride for the Treatment of Functional Dyspepsia     (11/May/2010)


Functional Dyspepsia (FD) is a common affliction in western countries effecting approximately 25% of the population. Due to its heterogeneous pathogenesis, effective therapeutics are limited. Mosapride, a serotonin receptor agonist with enterokinetic properties, has been evaluated for treating dyspeptic symptoms in a limited number of clinical trials. Most trials found...


Abstract
Full-text PDF

Gastric Acid-Related Diseases: Focus on Esomeprazole     (04/May/2010)


Esomeprazole (S-omeprazole) is a single optical enantiomer proton-pump inhibitor (PPI) approved for the management of gastro-oesophageal reflux disease, the prevention and treatment of Non-Steroidal Anti-Inflammatory Drugs (NSAID) associated gastric ulcer disease, treatment of duodenal ulcer disease associated with Helicobacter pylori infection, and the treatment of Zollinger- Ellison syndrome. Esomeprazole has...


Abstract
Full-text PDF

Infliximab: A Review of its use in the Treatment of Pediatric Crohn’s Disease     (29/Mar/2010)


The past decade has brought great change to the treatment of pediatric Crohn’s disease. The majority of affected patients now receive therapy directed at the underlying immune dysregulation that is associated with this chronic disease. The monoclonal antibodies directed against tumor necrosis factor alpha play an increasing role in such...


Abstract
Full-text PDF

A Phase II Study of S-1 Monotherapy as a First-line Combination Therapy of S-1 Plus Cisplatin as a Second-line Therapy, and Weekly Paclitaxel Monotherapy as a Third-line Therapy in Patients with Advanced Gastric Carcinoma: A Second Report     (24/Mar/2010)


Background: We have previously reported on a Phase II study of S-1 monotherapy as a first line, combination therapy of S-1 plus cisplatin as a second line, and weekly paclitaxel monotherapy as a third line therapy in patients with advanced gastric carcinomas. The median survival time (MST) of patients over...


Abstract
Pay-per-view

Pharmacotherapy of Ulcerative Colitis: What Role for Mesalamine?     (23/Mar/2010)


Goals of treatment for ulcerative colitis (UC) include inducing remission, reducing symptom burden, and maintaining disease quiescence. Mesalamine is indicated for the management of mild to moderate ulcerative colitis. There are various dosages, formulations, and mechanisms of delivery that are efficacious and currently utilized in the treatment of UC. Mesalamine...


Abstract
Full-text PDF

Relationship Between Celiac Disease Markers and Gastrointestinal Disease in Children with Autism     (19/Mar/2010)


Aim: This study was designed to determine if there is a relationship between celiac disease (CD) and the presence of gastrointestinal disease (GI) disease in children with autism. Subjects and Methods: One hundred twenty-two children were tested for IgG and IgA anti-transglutaminase autoantibodies (55 autistic children with GI disease, 28 non...


Abstract
Pay-per-view

Mosapride in the Treatment of Gastrointestinal Disorders     (16/Mar/2010)


Prokinetic drugs are being used with increasing frequency in the treatment of functional gastrointestinal disorders including functional dyspepsia (FD) and constipation-predominant Irritable Bowel Syndrome (IBS-C). Mosapride is a gastro-prokinetic agent that acts as a selective 5-HT4 agonist thereby accelerating gastric emptying. It has been used for the treatment of irritable...


Abstract
Full-text PDF

Hepatitis B Screening Compliance and Non-Compliance among Chinese, Koreans, Vietnamese and Cambodians     (05/Mar/2010)


Objective: The purpose of this community-based study was to determine factors associated with hepatitis B virus (HBV) screening compliance and non-compliance among Chinese, Korean, Vietnamese and Cambodian adults with varying levels of English language proficiency. Methods: A cross-sectional design was used consisting of a sample of 1,603 Asian adult men and...


Abstract
Full-text PDF

Is There a Relationship Between Autism and Gastrointestinal Disease?     (12/Feb/2010)


Is gastrointestinal disease more prevalent in children with autism? There are arguments favoring both sides of the controversy. We present data collected from the medical history of a recent Autistic Genetic Resource Exchange (AGRE) database of autistic children and their siblings, demonstrating that autistic children may be significantly more susceptible...


Abstract
Full-text PDF

A Review of the Treatment of Opioid-induced Constipation with Methylnaltrexone Bromide     (12/Feb/2010)


Objectives: Review and summarize the mechanism of action of methylnaltrexone bromide (methylnaltrexone) and its effectiveness in the treatment of opioid-induced constipation. Data Source: A multi-database search was conducted using PubMed and MEDLINE databases, in addition to electronic links to related articles and references. Background: Opioids are effective medications for the management of...


Abstract
Full-text PDF

Introductory Editorial     (10/Feb/2010)


Introductory Editorial by Dr Karna Dev Bardhan


Abstract
Full-text PDF

Clinical Presentation and Histologic Findings at Ileocolonoscopy in Children with Autistic Spectrum Disorder and Chronic Gastrointestinal Symptoms     (27/Jan/2010)


Background: Children with developmental disorders experience chronic gastrointestinal symptoms. Aims: To examine the nature of these gastrointestinal symptoms and histologic findings in children with autism spectrum/developmental disorders and ileocolonic disease. Methods: Chart review. 143 autism spectrum/developmental disorder patients, with chronic gastrointestinal symptoms, undergoing diagnostic ileocolonoscopy. Results: Diarrhea was present...


Abstract
Full-text PDF

Decreased Serum Cu/Zn SOD in Children with Autism     (14/Jan/2010)


Aim: To assess serum Cu/Zn SOD (Superoxide Dismutase) concentration in autistic children and evaluate its possible relationship to GI Symptoms. Subjects and Methods: Serum from 50 autistic children (31 with chronic digestive disease (most with ileo-colonic lymphoid nodular hyperplasia (LNH) and inflammation of the colorectum, small bowel and/or stomach) and 19...


Abstract
Full-text PDF

Decreased Serum Hepatocyte Growth Factor (HGF) in Autistic Children with Severe Gastrointestinal Disease     (27/Nov/2009)


Aim: To assess serum Hepatocyte Growth Factor (HGF) levels in autistic children with severe gastrointestinal (GI) disease and to test the hypothesis that there is a relationship between GI pathology and HGF concentration. Subjects and Methods: Serum from 29 autistic children with chronic digestive disease (symptoms for a minimum of 6–12...


Abstract
Full-text PDF

Common Variable Immunodeficiency Associated with Inflammatory Bowel Disease and Type I Diabetes     (27/Nov/2009)


Common variable immunodeficiency (CVID) is a heterogeneous group of primary immunodeficiency disorders characterized by defective antibody production, low levels of serum immunoglobulins and increased susceptibility to infection. The patient was a 39-year-old male who was admitted to the gastroenterology department with a two week history of diarrhea, blunt abdominal pain...


Abstract
Full-text PDF

Dexlansoprazole MR in the Management of Gastroesophageal Reflux Disease     (24/Nov/2009)


Dexlansoprazole MR, an enantiomer of lansoprazole, is a unique proton pump inhibitor with a duel release mechanism. This release mechanism produces two distinct peak concentrations that result in a prolonged mean residence time with increased duration of plasma concentrations and a greater percent time the pH is maintained above 4....


Abstract
Full-text PDF

A Review on the Use of Eltrombopag in Patients with Advanced Liver Disease     (13/Oct/2009)


Thrombocytopenia is the most common hematological abnormality in patients with chronic, advanced liver disease. In these patients, the presence of severe thrombocytopenia is an obstacle to the performance of invasive diagnostic and therapeutic procedures, and the current standard treatment for these patients is platelet transfusions, a remedy whose characteristics are...


Abstract
Full-text PDF

Intestinal Obstruction and Pheochromocytoma in a Patient Suffering from von Recklinghausen’s Disease     (13/Oct/2009)


GISTs are rare neoplasms, which were recently identified to be a distinct pathologic entity. They can develop in patients with neurofibromatosis type 1 (NF1) or may be sporadic. NF1 is one of the most common inherited diseases and is a complex disease, with patients having an increased prevalence of benign...


Abstract
Full-text PDF

Generalized Autoimmunity of ANCA and ASCA Related to Severity of Disease in Autistic Children with GI Disease     (08/Oct/2009)


Aim: To assess serum Anti-Neutrophil cytoplasmic Antibody (ANCA—PR3 and MPO) and Anti-Saccharomyces Cerevisiæ Antibody (ASCA) levels in autistic children with severe gastrointestinal (GI) disease and to test the hypothesis that there is generalized autoimmunity in a subpopulation of autistic children with severe GI disease and that this autoimmunity is associated...


Abstract
Full-text PDF

A Review of Multimatrix System (MMX) Mesalazine in the Management of Ulcerative Colitis     (06/Oct/2009)


MMXTM mesalazine is a novel delayed release mesalazine formulation with a high-strength 1.2 g tablet for the treatment of active mild to moderate colitis and maintenance of remission. In vitro and in vivo studies show initiation of drug release in the terminal ileum and caecum with gradual release of 5-ASA...


Abstract
Full-text PDF

The Role of Adjuvant Therapy in Gastrointestinal Stromal Tumor after Operative Treatment     (02/Oct/2009)


The treatment for localized advance gastrointestinal stromal tumor (GIST) is far from ideal. Up to 50% of patient developed post-operative recurrence and died within 5 years. Recently, imatinib was found to significantly improve recurrence-free survival in post-operative patients. The role of adjuvant therapy in high risk GIST patients is discussed....


Abstract
Full-text PDF

Infliximab: A Review of its Use in the Treatment of Crohn’s Disease     (25/Sep/2009)


Infliximab is a chimeric monoclonal antibody to human tumor necrosis factor alpha. While its use was developed in the treatment of rheumatologic diseases its effects on Crohn’s disease have revolutionized the management of this chronic illness. Infliximab has effects on both immune and epithelial cells leading to a reduction in...


Abstract
Full-text PDF

Fulminant Hepatic Failure Caused by Diffuse Liver Metastases Following Gastrointestinal Stromal Tumor Resection     (02/Sep/2009)


Metastatic tumors to the liver resulting in fulminant hepatic failure are a rare occurrence and have not been previously described in patients with gastrointestinal stromal tumor (GIST). A 70 year-old man was referred to hospital with postprandial discomfort. On examination a 19.5 cm large epithelioid GIST of the stomach was...


Article: Gastric Adenocarcinoma: Is Computed Tomography (CT) Useful in Preoperative Staging?
Full-text PDFAbstract

Gastric Adenocarcinoma: Is Computed Tomography (CT) Useful in Preoperative Staging?     (12/Aug/2009)


Background and Purpose: Although multiple studies testing the accuracy of CT in the preoperative staging of gastric adenocarcinoma have been carried out, their results are controversial. Whilst some authors claim that CT is an accurate method for preoperatively staging gastric cancer, others have advocated the contrary. Because of this discrepancy we have retrospectively reviewed preoperative CT findings compared with histopathological results in patients with gastric adenocarcinoma. Patients and Methods: Seventy-two patients diagnosed with gastric cancer who...


Abstract
Full-text PDF

A Review of Enteric-coated Mycophenolate Sodium  for Renal Transplant Immunosuppression     (07/Aug/2009)


Mycophenolic acid inhibits an enzyme, inosine monophosphate dehydrogenase (IMPDH), blocking purine synthesis of lymphocytes and therefore functioning as an effective immunosuppressive agent in transplantation. Currently, there are two available forms of mycophenolic acid (MPA) available; mycophenolate mofetil (MMF) and enteric-coated, delayed-release mycophenolate sodium (EC-MPS). Both products are approved for prophylaxis...


Abstract
Full-text PDF

Current and Prospective Pharmacotherapies in Gastroesophageal Reflux Disease     (05/Aug/2009)


Gastroesophageal reflux disease (GERD) is very common and is a costly problem to manage. The annual direct cost for managing the disease is estimated to be more than $9 billion dollars in the USA. In western populations, 25% of people over age 30 report having heartburn at least once a...


Abstract
Full-text PDF

Indications and Outcome of Endoscopic Papillectomy of the Major and Minor Papilla - a Prospective 5-year Study     (20/Jul/2009)


Endoscopic papillectomy is a promising and challenging endoscopic intervention. The aim of this study was i) to classify the differential indication, and ii) to study the outcome in papillectomy of suspicious tumor lesions of the papilla of Vater (papilla). Methods: Thirty nine patients were enrolled (22 males/17 females; range of age,...


Abstract
Full-text PDF

Revisiting the Use of Percutaneous Endoscopic Gastrostomy Tubes in Patients with Advanced Dementia     (13/Jul/2009)


Mr. Smith is an 85-year-old nursing home patient who has suffered from dementia for the past eight years. He has been bed bound and uncommunicative for the last six months. He was admitted with aspiration pneumonia three times in the past year. Over the last few months he has lost...


Abstract
Full-text PDF

Pharmacotherapy Update: Hyoscine Butylbromide in the Treatment of Abdominal Spasms     (23/Jun/2009)


Abdominal pain is one of the most common reasons why people seek medical care, and is often due to spasm of intra-abdominal visceral organs. Hyoscine butylbromide (HBB) is a quaternary ammonium compound which blocks the action of acetylcholine at parasympathetic sites (both muscarinic and nicotinic receptors) in smooth muscle, and...